Bromantane

Bromantane

Bromantane is a psychostimulant and anxiolytic drug of the adamantane family that is used in Russia in the treatment of neurasthenia. Bromantane is unique among antidepressants and anxiolytics due to its stimulant and anxiolytic properties.

History

Bromantane was first developed in Russia during the late 1980s. It was used by Russian athletes as a performance-enhancing drug during the 1996 Summer Olympics in Atlanta. Following this, the World Anti-Doping Agency (WADA) added Bromantane to the list of prohibited substances in sport in 1997.

Pharmacology

Bromantane is a derivative of adamantane, a bulky, hydrophobic molecule. It acts primarily by enhancing the activities of the dopamine and serotonin neurotransmitter systems in the brain. It is believed to increase the release of these neurotransmitters and inhibit their reuptake, leading to increased concentrations in the synaptic cleft.

Medical uses

Bromantane is used in the treatment of neurasthenia, a condition characterized by chronic fatigue and weakness, lack of motivation, and feeling of inadequacy. It is also used to treat asthenia, a similar condition characterized by chronic fatigue and lack of energy.

Side effects

Common side effects of Bromantane include dry mouth, nausea, headache, and dizziness. In rare cases, it can cause allergic reactions and hypersensitivity.

Legal status

In Russia, Bromantane is a prescription drug. It is not approved for use in the United States by the Food and Drug Administration (FDA), but it can be purchased online as a dietary supplement.

See also

• Adamantane
• Psychostimulant
• Anxiolytic
• Neurasthenia
• Asthenia